爱企查为您提供UNICANCER优宁康2023年企业商标信息查询,包括企业商标注册信息、商标logo,商标类别等企业商标信息查询,让您更轻松的了解UNICANCER优宁康商标信息,查询更多关于UNICANCER优宁康商标信息就到爱企查官网!
Institut National du Cancer, Ligue Nationale Contre le Cancer, and R&D Unicancer. Introduction The current standard of care for patients with locally advanced rectal cancer (stages T3, T4, or N+) includes chemoradiotherapy followed by total mesorectal excision.1 This multidisciplinary approach confers...
(INCa) and collaborative reflection of a French oncology intergroup (Thésaurus National de Cancérologie Digestive [TNCD], réseau de Groupes Coopérateurs en Oncologie [GCO] and Fédération Nationale des Centres de Lutte Contre le Cancer [UNICANCER]) enriched by the expertise of immunologists and ...
P2-18-03: Systemic Adjuvant Treatment of T1a and T1b N0M0 HER2+ Breast Carcinomas; an AERIO/UNICANCER Study.Background : Trials have shown benefit of adjuvant trastuzumab (TZM) for node-positive (N+) or T1c+ HER2positive breast... J Peron,Y Vano,JS Frenel,... - 《Cancer Research》...
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCOR... (2013) Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the ...
爱企查为您提供UNICANCER2023年企业商标信息查询,包括企业商标注册信息、商标logo,商标类别等企业商标信息查询,让您更轻松的了解UNICANCER商标信息,查询更多关于UNICANCER商标信息就到爱企查官网!
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial. 喜欢 0 阅读量: 62 作者: M Ychou,M Ychou,M Rivoire,M Rivoire...
Abstract OT1-1-05: Pernetta: A randomized phase II trial of pertuzumab + trastuzumab with or without chemotherapy, both followed by T-DM1 at progression, in patients with HER2-positive metastatic breast cancer - SAKK 22/10 / UNICANCER UC... Abstract OT1-1-05: Pernetta: A randomized ...
Bevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18 –UNICANCER GI). 喜欢 0 阅读量: 27 作者:S Hiret,S Hiret,C Borg,C Borg,A Bertaut,A Bertaut,O Bouche,O ...
Fabienne Thomas, David Ternant, Bruno Lacarelle, Jérôme Guitton, Joseph Ciccolini, and et al. 2021. "Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study"Pharmaceuticals14, no. 8: 796. https://doi.org/10.3390/...